André R A Marques Selected Research

André R A Marques Research Topics

Disease

6	Gaucher Disease (Gaucher's Disease) 03/2021 - 05/2015
4	Neuronal Ceroid-Lipofuscinoses (Neuronal Ceroid Lipofuscinosis) 12/2022 - 01/2020
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 01/2018
3	Fabry Disease (Fabry's Disease) 08/2016 - 02/2016
2	Lysosomal Storage Diseases (Lysosomal Storage Disease) 01/2023 - 03/2021
2	Atherosclerosis 01/2023 - 01/2021
2	Globoid Cell Leukodystrophy (Krabbe Disease) 01/2017 - 02/2016
1	Alzheimer Disease (Alzheimer's Disease) 12/2022
1	Synucleinopathies 01/2022
1	Myotonic Dystrophy (Dystrophia Myotonica) 01/2022
1	Parkinson Disease (Parkinson's Disease) 01/2022
1	Weight Loss (Weight Reduction) 10/2021
1	Gliosis 10/2021
1	Disease Progression 01/2021
1	Atherosclerotic Plaque (Atheroma) 01/2021
1	Blindness (Hysterical Blindness) 01/2020
1	Rare Diseases (Rare Disease) 01/2019
1	Nervous System Diseases (Neurological Disorders) 01/2017
1	Type C Niemann-Pick Disease (Niemann Pick Disease, Type C) 03/2016
1	Splenomegaly 05/2015
1	Cytopenia 05/2015
1	Bone Diseases (Bone Disease) 05/2015

Drug/Important Bio-Agent (IBA)

5	Glucosylceramidase (Glucocerebrosidase)IBA 01/2022 - 05/2015
4	EnzymesIBA 01/2023 - 05/2015
3	LDL Lipoproteins (beta Lipoproteins)IBA 01/2023 - 01/2020
3	Proteins (Proteins, Gene)FDA Link 12/2022 - 01/2020
3	Cathepsin DIBA 12/2022 - 01/2020
3	Cathepsin BIBA 01/2022 - 01/2020
3	SaposinsIBA 01/2022 - 01/2020
3	sphingosyl beta-glucosideIBA 03/2021 - 02/2016
2	Mannose (D-Mannose)IBA 01/2022 - 01/2020
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2022 - 01/2020
2	Phosphates (Orthophosphate)IBA 01/2022 - 01/2020
2	Lysosomal-Associated Membrane Protein 1IBA 01/2022 - 01/2020
2	Cathepsin LIBA 10/2021 - 01/2020
2	Protein AggregatesIBA 10/2021 - 01/2020
2	Glucosylceramides (Glucocerebrosides)IBA 03/2021 - 05/2015
2	CholesterolIBA 03/2021 - 03/2016
2	oxidized low density lipoproteinIBA 01/2021 - 01/2020
2	GlucosidasesIBA 01/2021 - 05/2015
2	Lysergic Acid Diethylamide (LSD)IBA 01/2021 - 01/2020
2	Psychosine (Galactosylsphingosine)IBA 01/2017 - 02/2016
1	LipidsIBA 01/2023
1	low density lipoprotein inhibitorIBA 01/2023
1	Amyloid beta-PeptidesIBA 12/2022
1	Protein Kinases (Protein Kinase)IBA 01/2022
1	Prion ProteinsIBA 01/2022
1	Amino Acids FDA Link 01/2022
1	Doxycycline (Periostat)FDA LinkGeneric 01/2022
1	Epidermal Growth Factor (EGF)IBA 01/2022
1	coomassie Brilliant BlueIBA 01/2022
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 01/2022
1	Amyloid beta-Protein Precursor (Amyloid Protein Precursor)IBA 01/2022
1	IGF Type 2 Receptor (Insulin-Like-Growth-Factor II Receptor)IBA 01/2022
1	Polymethyl Methacrylate (Sol)IBA 01/2022
1	3' Untranslated Regions (3' UTR)IBA 01/2022
1	SynucleinsIBA 01/2022
1	Peptide Hydrolases (Proteases)FDA Link 10/2021
1	SphingomyelinsIBA 03/2021
1	Lipoproteins (Lipoprotein)IBA 01/2021
1	Tripeptidyl-Peptidase 1IBA 01/2020
1	Lysosomal-Associated Membrane Protein 2IBA 01/2020
1	CeroidIBA 01/2020
1	LDL Receptors (LDL Receptor)IBA 01/2020
1	BuffersIBA 01/2020
1	procathepsin DIBA 01/2020
1	Adenosine Triphosphate (ATP)IBA 01/2020
1	Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA 01/2020
1	LipofuscinIBA 01/2020
1	Glial Fibrillary Acidic ProteinIBA 01/2020
1	EndocannabinoidsIBA 01/2018
1	Galactosylceramides (Galactocerebrosides)IBA 01/2017
1	GalactosylceramidaseIBA 01/2017
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 08/2016
1	GalactosidasesIBA 03/2016
1	ceramide glucosyltransferaseIBA 03/2016
1	GlycosphingolipidsIBA 02/2016
1	AcidsIBA 05/2015

Therapy/Procedure

3	Enzyme Replacement Therapy 01/2023 - 01/2020
2	Therapeutics 01/2019 - 01/2017